FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1105611000001109: Co-amoxiclav 250mg/125mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21998701000001112 Co-amoxiclav 250mg/125mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21998801000001115 Co-amoxiclav 250mg/125mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

10 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 250mg/125mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has VMP Co-amoxiclav 250mg/125mg tablets true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has VMP Co-amoxiclav 250mg/125mg tablets false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Is pack of Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has VMP Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets 100 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-amoxiclav 250mg/125mg tablets (A A H Pharmaceuticals Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (IVAX Pharmaceuticals UK Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Kent Pharma (UK) Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (GlaxoSmithKline) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Unichem Plc) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (PI) (Dowelhurst Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Teva UK Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Arrow Generics Ltd) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Waymade Healthcare Plc) 100 tablet Is a True Co-amoxiclav 250mg/125mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start